Suryo Rahmanto Y - Search Results

1

Siderocalin/Lcn2/NGAL/24p3 does not drive apoptosis through gentisic acid mediated iron withdrawal in hematopoietic cell lines.

Correnti C, Richardson V, Sia AK, Bandaranayake AD, Ruiz M, Suryo Rahmanto Y, Kovačević Ž, Clifton MC, Holmes MA, Kaiser BK, Barasch J, Raymond KN, Richardson DR, Strong RK. Correnti C, et al. Among authors: suryo rahmanto y. PLoS One. 2012;7(8):e43696. doi: 10.1371/journal.pone.0043696. Epub 2012 Aug 21. PLoS One. 2012. PMID: 22928018 Free PMC article.

2

N-myc downstream regulated 1 (NDRG1) is regulated by eukaryotic initiation factor 3a (eIF3a) during cellular stress caused by iron depletion.

Lane DJ, Saletta F, Suryo Rahmanto Y, Kovacevic Z, Richardson DR. Lane DJ, et al. Among authors: suryo rahmanto y. PLoS One. 2013;8(2):e57273. doi: 10.1371/journal.pone.0057273. Epub 2013 Feb 21. PLoS One. 2013. PMID: 23437357 Free PMC article.

3

Iron chelators for the treatment of cancer.

Yu Y, Gutierrez E, Kovacevic Z, Saletta F, Obeidy P, Suryo Rahmanto Y, Richardson DR. Yu Y, et al. Among authors: suryo rahmanto y. Curr Med Chem. 2012;19(17):2689-702. doi: 10.2174/092986712800609706. Curr Med Chem. 2012. PMID: 22455580 Review.

4

The melanoma tumor antigen, melanotransferrin (p97): a 25-year hallmark--from iron metabolism to tumorigenesis.

Suryo Rahmanto Y, Dunn LL, Richardson DR. Suryo Rahmanto Y, et al. Oncogene. 2007 Sep 13;26(42):6113-24. doi: 10.1038/sj.onc.1210442. Epub 2007 Apr 23. Oncogene. 2007. PMID: 17452986 Review.

5

Differential regulation of the Menkes and Wilson disease copper transporters by hormones: an integrated model of metal transport in the placenta.

Richardson DR, Suryo Rahmanto Y. Richardson DR, et al. Among authors: suryo rahmanto y. Biochem J. 2007 Mar 1;402(2):e1-3. doi: 10.1042/BJ20061844. Biochem J. 2007. PMID: 17300224 Free PMC article.

6

Generation and characterization of transgenic mice hyper-expressing melanoma tumour antigen p97 (Melanotransferrin): no overt alteration in phenotype.

Suryo Rahmanto Y, Richardson DR. Suryo Rahmanto Y, et al. Biochim Biophys Acta. 2009 Jul;1793(7):1210-7. doi: 10.1016/j.bbamcr.2009.02.003. Epub 2009 Feb 24. Biochim Biophys Acta. 2009. PMID: 19245822 Free article.

7

The medicinal chemistry of novel iron chelators for the treatment of cancer.

Kovacevic Z, Kalinowski DS, Lovejoy DB, Yu Y, Suryo Rahmanto Y, Sharpe PC, Bernhardt PV, Richardson DR. Kovacevic Z, et al. Among authors: suryo rahmanto y. Curr Top Med Chem. 2011;11(5):483-99. doi: 10.2174/156802611794785190. Curr Top Med Chem. 2011. PMID: 21192781 Review.

8

Resistance to the antineoplastic agent gallium nitrate results in marked alterations in intracellular iron and gallium trafficking: identification of novel intermediates.

Davies NP, Suryo Rahmanto Y, Chitambar CR, Richardson DR. Davies NP, et al. Among authors: suryo rahmanto y. J Pharmacol Exp Ther. 2006 Apr;317(1):153-62. doi: 10.1124/jpet.105.099044. Epub 2005 Dec 22. J Pharmacol Exp Ther. 2006. PMID: 16373528

9

Iron uptake and metabolism in the new millennium.

Dunn LL, Suryo Rahmanto Y, Richardson DR. Dunn LL, et al. Among authors: suryo rahmanto y. Trends Cell Biol. 2007 Feb;17(2):93-100. doi: 10.1016/j.tcb.2006.12.003. Epub 2006 Dec 27. Trends Cell Biol. 2007. PMID: 17194590 Review.

10

Bp44mT: an orally active iron chelator of the thiosemicarbazone class with potent anti-tumour efficacy.

Yu Y, Suryo Rahmanto Y, Richardson DR. Yu Y, et al. Among authors: suryo rahmanto y. Br J Pharmacol. 2012 Jan;165(1):148-66. doi: 10.1111/j.1476-5381.2011.01526.x. Br J Pharmacol. 2012. PMID: 21658021 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

38 results

Search Page

Filters